![Brook Riggins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brook Riggins
Director of Finance/CFO at
THIOGENESIS THERAPEUTICS, CORP.
Net worth: 468 300 $ as of 30/05/2026
Profile
Brook G.
Riggins is currently Chief Financial Officer & Director at Thiogenesis Therapeutics, Inc., Chief Financial Officer, Secretary & Director at Thiogenesis Therapeutics Corp.
since 2018, and Principal at Beruscha Capital Sro since 2010.
Former roles include Director at Pulse Capital Corp.
in 2011, Director at Aurora Solar Technologies, Inc. from 2011 to 2012, Director, Chief Executive & Financial Officer at Rozdil Capital Corp., Vice President at Canaccord Adams Ltd., Chief Investment Officer at Limetree Capital AG from 2008 to 2010, Vice President-Finance at Genetronics Biomedical Corp.
from 2002 to 2004, and a position at the University of British Columbia.
Education includes an undergraduate degree from the University of British Columbia and an MBA from The Schulich School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/07/2025 | 1,050,000 ( 2.03% ) | 468 300 $ | 30/05/2026 |
Brook Riggins active positions
| Companies | Position | Start |
|---|---|---|
| THIOGENESIS THERAPEUTICS, CORP. | Director of Finance/CFO | 02/05/2018 |
Beruscha Capital Sro | Corporate Officer/Principal | 30/11/2010 |
Former positions of Brook Riggins
| Companies | Position | End |
|---|---|---|
| AURORA SOLAR TECHNOLOGIES INC. | Director/Board Member | 29/02/2012 |
Pulse Capital Corp.
 Pulse Capital Corp. Financial ConglomeratesFinance Capital Pool Company | Director/Board Member | 07/12/2011 |
Limetree Capital AG | Chief Investment Officer | 30/06/2010 |
Genetronics Biomedical Corp.
 Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Director of Finance/CFO | 31/12/2003 |
Canaccord Adams Ltd.
 Canaccord Adams Ltd. Investment Banks/BrokersFinance Provides corporate finance, investment advice and brokerage services | Corporate Officer/Principal | - |
Training of Brook Riggins
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Genetronics Biomedical Corp.
Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Commercial Services |
Pulse Capital Corp.
Pulse Capital Corp. Financial ConglomeratesFinance Capital Pool Company | Finance |
Canaccord Adams Ltd.
Canaccord Adams Ltd. Investment Banks/BrokersFinance Provides corporate finance, investment advice and brokerage services | Finance |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limetree Capital AG | |
Aurora Solar Technologies, Inc.
 Aurora Solar Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and markets quality control systems for the solar cell manufacturing industry | Electronic Technology |
The Schulich School of Business
 The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rozdil Capital Corp.
 Rozdil Capital Corp. Financial ConglomeratesFinance Operates as capital pool company | Finance |
Beruscha Capital Sro | |
Thiogenesis Therapeutics Corp.
 Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
- Stock Market
- Insiders
- Brook Riggins
